Search
for
Sort by
Research 391–420 of 1000+
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- South Asian Epidemic of Antifungal Therapeutic Failures: Congress Proceedings and Take-home Messages. First International Congress of SAARCUM: South Asian Alliance against Recalcitrant Cutaneous Mycosis. 17 November 2018, Medanta – The Medicity, Gurugram, India
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- An ROS‐Scavenging Treg‐Recruiting Hydrogel Patch for Diabetic Wound Healing
- Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease
- 42905 Role of regulatory T and T-helper 17 cells in patients with acute diffuse and total alopecia
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Baricitinib as a treatment for myasthenia gravis: A case report
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- A new TH17 cytokine in hidradenitis suppurativa: antimicrobial and pro-inflammatory role of IL-26
- 068 Pathogenic Th17 cells, CD8+CD69+CD49a- tissue-resident memory T cells and common γ chain receptor + natural killer cells express more IL-17, compared to IFN-γ, under the foxp3+ memory regulatory T cells-depleted microenvironment in patients with chronic alopecia areata
- A human vitamin D receptor mutation causes rickets and impaired Th1/Th17 responses
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Novel therapies for alopecia areata: The era of rational drug development
- Onset of frontal fibrosing alopecia during inhibition of Th1/17 Pathways with ustekinumab
- Essential Role of STAT3 Signaling in Hair Follicle Homeostasis
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecia Areata: A Complex Cytokine Driven Disease
- Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis